HMPC: overview of assessment work - priority list

EMA decision on adoption by analogy of Commission decision C (2025) 2495

Human medicines European public assessment report (EPAR): Protopic, tacrolimus, Date of authorisation: 27/02/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Revision: 1, Status: Authorised

Keeping medicines safe: Reporting side effects can make medicines safer for everyone

Safety of medicines

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 January 2026, 15:00 (CET) to 15 January 2026, 16:00 (CET)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 February 2026, 15:00 (CET) to 12 February 2026, 16:00 (CET)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 March 2026, 15:00 (CET) to 12 March 2026, 16:00 (CET)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)